Supreme Court Considers Validity of Gene Patents
The United States Supreme Court heard arguments last month in
Association for Molecular Biology v. Myriad Genetics, Inc., et al, the landmark lawsuit challenging whether isolated human genes are patentable. The case questions Myriad Genetics’ right to patent BRCA1 and BRCA2, two genes that correlate to increased rates of breast and ovarian cancer.
Read more